| Literature DB >> 20058195 |
Kenneth Taymor1, Christopher Thomas Scott.
Abstract
The executive order and issuance of federal guidelines for human embryonic stem cell research are positive developments and will produce long-term benefits by creating a new registry for hESC lines. But there may be short-term costs caused by regulatory uncertainty, procedural delay, and knock-on effects as national policies are adopted at state and local jurisdictions. Policymakers must ensure that national mechanisms of oversight for a new hESC registry are adequately funded, properly organized, transparent, and free of bureaucratic detail.Entities:
Mesh:
Year: 2009 PMID: 20058195 DOI: 10.1007/s12015-009-9091-z
Source DB: PubMed Journal: Stem Cell Rev Rep ISSN: 2629-3277 Impact factor: 5.739